Afficher la couverture 'Tumor-intrinsic sensitivity to the pro-apoptotic effects of IFN-γ is a major determinant of CD4+ CAR T-cell antitumor activity | Boulch, Morgane' en grand format
/5

0 avis

Tumor-intrinsic sensitivity to the pro-apoptotic effects of IFN-γ is a major determinant of CD4+ CAR T-cell antitumor activity

Archive ouverte

Boulch, Morgane | Cazaux, Marine | Cuffel, Alexis | Guerin, Marion | Garcia, Zacarias | Alonso, Ruby | Lemaître, Fabrice | Beer, Alexander | Corre, Béatrice | Menger, Laurie | Grandjean, Capucine | Morin, Florence | Thieblemont, Catherine | Caillat-Zucman, Sophie | Bousso, Philippe

Edité par CCSD ; Nature Research -

International audience. Abstract CD4 + T cells and CD4 + chimeric antigen receptor (CAR) T cells display highly variable antitumor activity in preclinical models and in patients; however, the mechanisms dictating how and when CD4 + T cells promote tumor regression are incompletely understood. With the help of functional intravital imaging, we report that interferon (IFN)-γ production but not perforin-mediated cytotoxicity was the dominant mechanism for tumor elimination by anti-CD19 CD4 + CAR T cells. Mechanistically, mouse or human CD4 + CAR T-cell-derived IFN-γ diffused extensively to act on tumor cells at distance selectively killing tumors sensitive to cytokine-induced apoptosis, including antigen-negative variants. In anti-CD19 CAR T-cell-treated patients exhibiting elevated CAR CD4:CD8 ratios, strong induction of serum IFN-γ was associated with increased survival. We propose that the sensitivity of tumor cells to the pro-apoptotic activity of IFN-γ is a major determinant of CD4 + CAR T-cell efficacy and may be considered to guide the use of CD4 + T cells during immunotherapy.

Suggestions

Du même auteur

A crosstalk between CAR T cell subsets and the tumor microenvironment is essential for sustained cytotoxic activity

Archive ouverte | Boulch, Morgane | CCSD

International audience. Chimeric antigen receptor (CAR) T cell therapy relies on the activity of a large pool of tumor-targeting cytotoxic effectors. Whether CAR T cells act autonomously or require interactions with...

A major role for CD4+ T cells in driving cytokine release syndrome during CAR T cell therapy

Archive ouverte | Boulch, Morgane | CCSD

International audience. Anti-CD19 chimeric antigen receptor (CAR) T cell therapy represents a breakthrough for the treatment of B cell malignancies. Yet, it can lead to severe adverse events, including cytokine rele...

Single-cell imaging of CAR T cell activity in vivo reveals extensive functional and anatomical heterogeneity

Archive ouverte | Cazaux, Marine | CCSD

International audience. CAR T cells represent a potentially curative strategy for B cell malignancies. However, the outcome and dynamics of CAR T cell interactions in distinct anatomical sites are poorly understood....

Chargement des enrichissements...